This is moving towards a suite of gold standard products for CA detection
suBb2m pan cancer probe - 100% / 100% - whole of population screening ; refer for location of CA using this 'red alert' screen to narrow down the location;
Bard1 - using 2 proteins & CA125 = location of the CA - eg Ovarian -refer for specialist review
current numbers = gold standard
Currently the approach to Ov CA used algorithms, and minimum 5 markers - with less sensitivity & specificity than BD1
This company is looking to be the gold standard here and their eye to the detail eg the fewest number of proteins possible while maintaining gold standard is forward looking. Looking for a range of $700 - 850m market cap
Ann: Positive Results from the BARD1 Autoantibody Assay, page-25
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.5¢ |
Change
0.030(5.31%) |
Mkt cap ! $66.16M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 60.5¢ | 57.0¢ | $21.86K | 36.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1009 | 58.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 11650 | 6 |
View Market Depth
| Last trade - 12.34pm 10/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |